According to Edgewise, these preclinical findings suggest that EDG-5506 has superior disease-modifying potential relative to gene therapy and exon ...
https://www.google.com/url?rct=j&sa=t&url=https://musculardystrophynews.com/2021/11/02/first-bmd-patients-dosed-in-trial-of-oral-therapy-edg-5506/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNG8Tmp09MtsGMx0r01TSnxPi0Dj2A
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.